FierceBiotech 2026-02-26 Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
FierceBiotech 2026-02-26 Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial
FierceBiotech 2026-02-26 Quantum Surgical snaps up J&J's NeuWave Medical for its microwave ablation technology
FierceBiotech 2026-02-26 Protagonist plans to pocket $400M from Takeda rather than split US rusfertide profits
FierceBiotech 2026-02-26 Accent halts solid tumor trial over adverse events, pivots to other lead cancer program
FierceBiotech 2026-02-25 Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
FierceBiotech 2026-02-25 Charles River sells manufacturing and discovery businesses to fulfill promised pivot
FierceBiotech 2026-02-25 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
FierceBiotech 2026-02-25 After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
FierceBiotech 2026-02-25 GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug
FierceBiotech 2026-02-25 After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst
FierceBiotech 2026-02-24 Evinova reels in AI clinical development deals with Astellas and AstraZeneca
FierceBiotech 2026-02-24 GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech
FierceBiotech 2026-02-24 Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics